• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.

作者信息

Caffo O, Zagonel V, Baldessari C, Berruti A, Bortolus R, Buti S, Ceresoli G L, Donini M, Ermacora P, Fornarini G, Fratino L, Masini C, Massari F, Mosca A, Mucciarini C, Procopio G, Tucci M, Verri E, Zucali P, Buttigliero C

机构信息

Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.

Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

出版信息

Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.

DOI:10.1016/j.annonc.2020.06.005
PMID:32562741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7299865/
Abstract
摘要

相似文献

1
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.关于前列腺癌雄激素剥夺治疗与严重急性呼吸综合征冠状病毒2感染风险之间的关系。
Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
2
Does androgen deprivation therapy protect against severe complications from COVID-19?雄激素剥夺疗法能预防新冠病毒病的严重并发症吗？
Ann Oncol. 2020 Oct;31(10):1419-1420. doi: 10.1016/j.annonc.2020.06.023. Epub 2020 Jul 9.
3
Androgen deprivation and SARS-CoV-2 in men with prostate cancer.前列腺癌男性患者的雄激素剥夺与新型冠状病毒肺炎
Ann Oncol. 2020 Oct;31(10):1417-1418. doi: 10.1016/j.annonc.2020.06.015. Epub 2020 Jun 29.
4
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
5
Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?前列腺癌患者接受雄激素剥夺治疗能预防新型冠状病毒肺炎吗？
Rev Assoc Med Bras (1992). 2020 Oct;66(10):1314-1315. doi: 10.1590/1806-9282.66.10.1314.
6
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.安全第一：COVID-19期间不使用雄激素剥夺疗法而延迟根治性前列腺切除术的证据
Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
7
COVID-19 and The Prostate Cancer Connection.新型冠状病毒肺炎与前列腺癌的关联
Can J Urol. 2020 Oct;27(5):10346.
8
[Can androgen deprivation therapy play a protective role in SARS-CoV-infections?].雄激素剥夺疗法在严重急性呼吸综合征冠状病毒感染中能发挥保护作用吗？
Urologe A. 2020 Oct;59(10):1251-1253. doi: 10.1007/s00120-020-01305-7.
9
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
10
Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.台湾地区新冠肺炎（COVID-19）与严重急性呼吸综合征（SARS）临床特征比较。
Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14.

引用本文的文献

1
A Comment on Coronavirus Disease 2019 and the Hair.关于2019冠状病毒病与头发的评论
Int J Trichology. 2024 Jan-Dec;16(1-6):1-5. doi: 10.4103/ijt.ijt_179_20. Epub 2025 Apr 18.
2
Antiandrogens as Therapies for COVID-19: A Systematic Review.抗雄激素作为COVID-19的治疗方法：一项系统综述
Cancers (Basel). 2024 Jan 10;16(2):298. doi: 10.3390/cancers16020298.
3
[Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].[前列腺癌、雄激素剥夺与新型冠状病毒肺炎感染风险：一项系统评价与荟萃分析]
Prog Urol. 2022 Dec;32(16):1421-1430. doi: 10.1016/j.purol.2022.09.005. Epub 2022 Sep 13.
4
Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：系统评价和荟萃分析。
J Korean Med Sci. 2022 Aug 8;37(31):e237. doi: 10.3346/jkms.2022.37.e237.
5
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.雄激素剥夺疗法对前列腺癌男性 COVID-19 疾病的影响。
JNCI Cancer Spectr. 2022 May 2;6(3). doi: 10.1093/jncics/pkac035.
6
Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial.雄激素抑制对 COVID-19 住院男性临床结局的影响：HITCH 随机临床试验。
JAMA Netw Open. 2022 Apr 1;5(4):e227852. doi: 10.1001/jamanetworkopen.2022.7852.
7
The clinical impact of androgen deprivation therapy on SARS-CoV-2 infection rates and disease severity.雄激素剥夺疗法对新型冠状病毒感染率和疾病严重程度的临床影响。
Turk J Urol. 2021 Nov;47(6):495-500. doi: 10.5152/tud.2021.21278.
8
Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review.严重急性呼吸综合征冠状病毒 2 感染前列腺癌患者：批判性评价。
Crit Rev Oncol Hematol. 2021 Nov;167:103491. doi: 10.1016/j.critrevonc.2021.103491. Epub 2021 Oct 6.
9
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.雄激素剥夺疗法与 COVID-19 大流行初始阶段男性前列腺癌患者的超额死亡率。
PLoS One. 2021 Oct 7;16(10):e0255966. doi: 10.1371/journal.pone.0255966. eCollection 2021.
10
Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.雄激素剥夺疗法对前列腺癌患者 COVID-19 严重程度的影响。
Prostate. 2021 Dec;81(16):1349-1354. doi: 10.1002/pros.24232. Epub 2021 Sep 13.

本文引用的文献

1
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.